Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC4 | O15439 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.64 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.61 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.61 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.61 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.61 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.61 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.61 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.61 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.55 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.55 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28032595 | 0.98 | LMNA (0.63) | ABCC4LMNAGAATSHRPTGS1 | |
| Methyl Alcohol SCHEMBL7855784 | 0.96 | ABCC4 (0.62) | ABCC4LMNAGAATSHRPTGS1 | |
| SCHEMBL9251496 | 0.92 | ABCC4 (0.74) | ABCC4LMNAGAATSHRPTGS1 | |
| SCHEMBL27604987 | 0.89 | LMNA (0.68) | ABCC4LMNAGAATSHRPTGS1 | |
| SCHEMBL3417462 | 0.89 | GRIN2D (0.59) | ABCC4LMNAGAATSHRPTGS1 | |
| SCHEMBL7030142 | 0.88 | ACMSD (0.58) | ABCC4LMNAGAATSHRPTGS1 | |
| SCHEMBL17187933 | 0.88 | PLA2G10 (0.60) | ABCC4LMNAGAATSHRPTGS1 | |
| SCHEMBL3437800 | 0.88 | AOC3 (0.53) | ABCC4LMNAGAATSHRPTGS1 | |
| SCHEMBL23296113 | 0.87 | GRIN2D (0.57) | ABCC4LMNAGAATSHRPTGS1 | |
| SCHEMBL3936298 | 0.87 | PRKCI (0.64) | ABCC4LMNAGAATSHRPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150025020-A1 | SELF-PRESERVED OIL DISPERSIONS COMPRISING BORIC ACID | SANTEN SAS (FR) | 2015-01-22 | — | — | US | claimed |
| EP-2816998-A1 | SELF-PRESERVED OIL DISPERSIONS COMPRISING BORIC | Santen SAS (FR) | 2014-12-31 | — | — | EP | claimed |
| WO-2013124415-A1 | SELF-PRESERVED OIL DISPERSIONS COMPRISING BORIC | NOVAGALI PHARMA SA (FR) | 2013-08-29 | — | — | WO | claimed |
| EP-2630952-A1 | Self-preserved oil dispersions comprising boric acid | Novagali Pharma S.A. (FR) | 2013-08-28 | — | — | EP | claimed |
| US-7034187-B2 | Poly(aralkyl ketone)s and methods of preparing the same | AGENCY FOR SCIENCE, TECHNOLOGY, AND RESEARCH (SG) | 2006-04-25 | — | — | US | claimed |
| US-20050272905-A1 | NOVEL POLY(ARALKYL KETONE)S AND METHODS OF PREPARING THE SAME | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH | 2005-12-08 | — | — | US | claimed |
| US-20020032174-A1 | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade | PHARMACIA CORPORATION | 2002-03-14 | — | — | US | claimed |
| JP-1249720-A | — | — | None | — | — | JP | disclosed |
| EP-4727537-A2 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | Adaxion Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| WO-2025235527-A1 | CRYSTALLINE FORMS OF A PPAR ALPHA ANTAGONIST | TEMPEST THERAPEUTICS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| US-12378224-B2 | Heteroaryl compounds and their use as Mer inhibitors | DONG-A SOCIO HOLDINGS CO., LTD. (KR) | 2025-08-05 | — | — | US | disclosed |
| US-20250213560-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS HAVING PHENYL GROUP AND USES THEREOF | BNH RESEARCH CO., LTD. (KR) | 2025-07-03 | — | — | US | disclosed |
| US-20250064941-A1 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | ADAXION THERAPEUTICS, INC. | 2025-02-27 | — | — | US | disclosed |
| EP-0535034-A1 | PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-04-07 | — | — | EP | disclosed |
| CN-1058208-A | PHARMACEUTICAL COMPOUNDS | WELLCOME FOUND (GB) | 1992-01-29 | — | — | CN | disclosed |
| WO-1991019700-A1 | PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-12-26 | — | — | WO | disclosed |
| US-4971979-A | Antiinflammatory agents | RHONE-POULENC SANTE (FR) | 1990-11-20 | — | — | US | disclosed |
| US-4886835-A | ANTIINFLAMMATORY AGENTS | RHONE-POULENC SANTE (FR) | 1989-12-12 | — | — | US | disclosed |
| JP-H01249720-A | SUPPOSITORY | AMERICAN CYANAMID CO | 1989-10-05 | — | — | JP | disclosed |
| US-4493844-A | Insecticidal 2,2'-bridged(1,1'-biphenyl)-3-ylmethyl carboxamides | FMC CORPORATION (US) | 1985-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378224-B2 | Heteroaryl compounds and their use as Mer inhibitors | MERTK, RET, ERBB2 | ABCC4 354/4885LMNA 1144/4885GAA 1225/4885 |
| US-20050272905-A1 | NOVEL POLY(ARALKYL KETONE)S AND METHODS OF PREPARING THE SAME | ADSL, KHK, PKLR | ABCC4 2849/4885LMNA 210/4885GAA 1268/4885 |
| US-20250213560-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS HAVING PHENYL GROUP AND USES THEREOF | PNMT, BDNF, NLN | ABCC4 1904/4885LMNA 3008/4885GAA 666/4885 |
| US-20250064941-A1 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | SIGLEC7, SIGLEC9, CD2BP2 | ABCC4 3837/4885LMNA 2421/4885GAA 525/4885 |
| US-20020032174-A1 | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade | TFPI, PLAT, TFPI2 | ABCC4 1647/4885LMNA 689/4885GAA 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.